5α-Reductases in human breast carcinoma: Possible modulator of in situ androgenic actions

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 5, 2001, Pages 2250-2257

  Suzuki, Takashi ^a   Darnel, Andrew D ^a   Akahira, Jun Ichi ^a   Ariga, Naohiro ^b   Ogawa, Sayaka ^a   Kaneko, Chika ^a   Takeyama, Junji ^a   Moriya, Takuya ^b   Sasano, Hironobu ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; STEROID 5ALPHA REDUCTASE; STEROID 5ALPHA REDUCTASE 1; STEROID 5ALPHA REDUCTASE 2; UNCLASSIFIED DRUG; 3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; ANDROGEN RECEPTOR; ANDROSTANOLONE; HYDROXYSTEROID DEHYDROGENASE; ISOENZYME;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER CELL; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME; BREAST TUMOR; ENZYMOLOGY; GENETICS; METABOLISM; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY;

17-HYDROXYSTEROID DEHYDROGENASES; 3-HYDROXYSTEROID DEHYDROGENASES; ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DIHYDROTESTOSTERONE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MIDDLE AGED; RECEPTORS, ANDROGEN; RECEPTORS, PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TESTOSTERONE 5-ALPHA-REDUCTASE;

EID: 0034744032     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.5.2250     Document Type: Article

References (46)

1. Thomas DB. 1984 Do hormones cause cancer? Cancer. 53:595-604.
2. Vihko R, Apter D. 1989 Endogenous steroids in the pathophysiology of breast cancer. CRC Crit Rev Oncol Hematol. 9:1-16.
3. CO human breast cancer cells by progestins: implications for endocrine therapies. Cancer Res. 45:167-173.
4. Poulin R, Baker D, Labrie F. 1988 Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line. Breast Cancer Res Treat. 12:213-225.
5. Santen RJ, Manni A, Harvey H, Redmond C. 1990 Endocrine treatment of breast cancer in women. Endocr Rev. 11:221-265.
6. Adams JB. 1988 Adrenal androgens and human breast cancer: a new appraisal. Breast Cancer Res Treat. 51:183-188.
7. Allred DC, Harvey JM, Berardo M, Clark GM. 1998 Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol. 11:155-168.
8. Isola JJ. 1993 Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors. J Pathol. 170:31-35.
9. Bryan RM, Mercer RJ, Bennett RC, Rennie GC, Lie TH, Morgan FJ. 1984 Androgen receptors in breast cancer. Cancer. 54:2436-2440.
10. Graham JD, Yeates C, Balleine RL, et al. 1996 Progesterone receptor A and B protein expression in human breast cancer. J Steroid Biochem Mol Biol. 56:93-98.
11. Russell DW, Wilson JD. 1994 Steroid 5α-reductase: two genes/two enzymes. Annu Rev Biochem. 63:25-61.
12. Thigpen AE, Silver RI, Guileyardo JM, Casey ML, McConnell JD, Russell DW. 1993 Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression. J Clin Invest. 92:903-910.
13. Thigpen AE, Davis DL, Milatovich A, et al. 1992 Molecular genetics of steroid 5α-reductase 2 deficiency. J Clin Invest. 90:799-809.
14. Chen W, Zouboulis ChC, Orfanos CE. 1996 The 5α-reductase system and its inhibitors. Dermatology. 193:177-184.
15. Perel E, Daniilescu D, Kharlip L, Blackstein ME, Killinger DW. 1985 The relationship between growth and androstenedione metabolism in four cell lines of human breast carcinoma cells in culture. Mol Cell Endocrinol. 41:197-203.
16. Wiebe JP, Muzia D, Hu J, Szwajcer D, Hill SA, Seachrist JL. 2000 The 4-pregnene and 5α-pregnane progesterone metabolites formed in nontumorous and tumorous breast tissue have opposite effects on breast cell proliferation and adhesion. Cancer Res. 60:936-943.
17. Bloom HJG, Richardson WW. 1957 Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer. 11:359-377.
18. Elston CW, Ellis IO. 1991 Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer. Experience from a large study with long-term follow-up. Histopathology. 19:403-410.
19. Pelletier G, Luu-The V, Tetu B, Labrie F. 1999 Immunocytochemical localization of type 5 17β-hydroxysteroid dehydrogenase in human reproductive tissues. J Histochem Cytochem. 47:731-738.
20. Silver RI, Wiley EL, Thigpen AE, Guileyardo JM, McConnell JD, Russell DW. 1994 Cell type specific expression of steroid 5α-reductase 2. J Urol. 152:438-442.
21. 4-isomerase from placenta: expression in non-steroidogenic cells of a protein that catalyzes the dehydrogenation/isomerization of C21 and C19 steroids. Endocrinology. 126:2493-2498.
22. Sasano H, Mason JI, Sasano N, Nagura H. 1990 Immunolocalization of 3β-hydroxysteroid dehydrogenase in human adrenal cortex and its disorders. Endocr Pathol. 1:94-101.
23. Labrie F, Simard J, Luu-The V, et al. 1992 Structure and tissue-specific expression of 3β-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase genes in human and rat classical and peripheral steroidogenic tissues. J Steroid Biochem Mol Biol. 41:421-435.
24. Mote PA, Balleine RL, McGowan EM, Clarke CL. 1999 Colocalization of progesterone receptors A and B by dual immunofluorescent histochemistry in human endometrium during the menstrual cycle. J Clin Endocrinol Metab. 84:2963-2971.
25. Clarke CL, Zaino RJ, Feil PD, et al. 1987 Monoclonal antibodies to human progesterone receptor: characterization by biochemical and immunohistochemical techniques. Endocrinology. 121:1123-1132.
26. Suzuki T, Sasano H, Kimura N, et al. 1994 Immunohistochemical distribution of progesterone, androgen and oestrogen receptors in the human ovary during the menstrual cycle: relationship to expression of steroidogenic enzymes. Hum Reprod. 9:1589-1595.
27. Delos S, Carsol JL, Fina F, Raynaud JP, Martin PM. 1998 5α-Reductase and 17β-hydroxysterold dehydrogenase expression in epithelial cells from hyper-plastic and malignant human prostate. Int J Cancer. 75:840-846.
28. Andersson S, Berman DM, Jenkins EP, Russell DW. 1991 Deletion of steroid 5α-reductase 2 gene in male pseudohermaphroditism. Nature. 354:159-161.
29. Zhu X, Daffada AAI, Chan CMW, Dowsett M. 1997 Identification of an exon 3 deletion splice variant androgen receptor mRNA in human breast cancer. Int J Cancer. 72:574-580.
30. Willey JC, Crawford EL, Jackson CM, et al. 1998 Expression measurement of many genes simultaneously by quantitative RT-PCR using standardized mixtures of competitive templates. Am J Respir Cell Mol Biol. 19:6-17.
31. MacIndoe JH, Woods GR. 1981 Steroid-metabolizing enzymes in human breast cancer cells. II. 5α-Reductase, 3α-hydroxysteroid oxidoreductase, and 17β-hydroxysteroid oxidoreductase. Endocrinology. 108:1407-1413.
32. Cheng Y, Prusoff WH. 1973 Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (150) of an enzymatic reaction. Biochem Pharmacol. 22:3099-3108.
33. Abraham GE. 1974 Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle. J Clin Endocrinol Metab. 39:340-346.
34. Vermeulen A, Verdonck L. 1979 Factors affecting- sex hormone levels in postmenopausal women. J Steroid Biochem. 11:899-904.
35. 19-steroids and oestradiol levels in human primary breast tumour tissues and their correlation with androgen and oestrogen receptors. J Steroid Biochem. 24:1117-1125.
36. Recchione C, Venturelli E, Manzari A, Cavalleri A, Martinetti A, Secreto G. 1995 Testosterone, dihydrotestosterone and oestradiol levels in postmenopausal breast cancer tissues. J Steroid Biochem Mol Biol. 52:541-546.
37. Dufort I, Rheault P, Huang XF, Soucy P, Luu-The V. 1999 Characteristics of a highly labile human type 5 17β-hydroxysteroid dehydrogenase. Endocrinology. 140:568-574.
38. El-Alfy M, Luu-The V, Huang XF, Berger L, Labrie F, Pelletier G. 1999 Localization of type 5 17β-hydroxysteroid dehydrogenase, 3β-hydroxysteroid dehydrogenase, and androgen receptor in the human prostate by in situ hybridization and immunocytochemistry. Endocrinology. 140:1481-1491.
39. Gunasegaram R, Peh KL, Loganath A, Ratnam SS. 1998 Expression of 3β-hydroxysteroid dehydrogenase-5,4-en isomerase activity by infiltrating ductal human breast carcinoma in vitro. Breast Cancer Res Treat. 50:117-123.
40. Sasano H, Nagura H, Harada N, Goukon Y, Kimura M. 1994 Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders. Hum Pathol. 25:530-535.
41. Gerdes J, Schwab U, Lemke H, Stein H. 1983 Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer. 31:13-20.
42. Veronese SM, Gambacorta M, Gottardi O, Scanzi F, Ferrari M, Lampertico P. 1993 Proliferation index as a prognostic marker in breast cancer. Cancer. 71:3926-3931.
43. Miller WR, Hawkins RA, Forrest AM. 1982 Significance of aromatase activity in human breast cancer. Cancer Res. 42:3365-3368.
44. Poutanen M, Isomaa V, Lehto VP, Vihko R. 1992 Immunohistochemical analysis of 17β-hydroxysteroid dehydrogenase in benign and malignant human breast tissue. Int J Cancer. 50:386-390.
45. Sasano H, Frost AR, Saltoh R, et al. 1996 Aromatase and 17β-hydroxysteroid dehydrogenase type 1 in human breast carcinoma. J Clin Endocrinol Metab. 81:4042-4046.
46. Suzuki T, Moriya T, Ariga N, Kaneko C, Kanazawa M, Sasano H. 2000 17β-Hydroxysteroid dehydrogenase type 1 and type 2 in human breast carcinoma: a correlation to clinicopathological parameters. Br J Cancer. 82: 524-528.